The purpose of this project is to identify and target barriers faced by rural endometrial cancer patients in order to develop a patient navigation intervention. Rural residents with endometrial cancer, the most prevalent gynecologic cancer in the US, have higher odds of mortality than urban endometrial cancer patients. As the number of new endometrial cancer cases is expected to increase 50% by 2030, this urban-rural disparity is expected to continue widening.

The purpose of this project is to evaluate the following: 1. Are registered pharmacists in North Carolina aware of their authority as immunizing pharmacists to dispense, deliver or administer self-administered oral or transdermal contraceptives to a patient; 2. Of pharmacists that have registered for and completed the NC hormonal contraceptive training, how many have implemented this service for patients; and 3. Complete semi-structured interviews of pharmacists that have or have not implemented the service to understand their motivations and perceptions of and ability to expand access to hormonal contraception and/or address barriers to implementation.

We are conducting this study to better understand the relationship between access to care, financial stress and health related quality of life among cancer patients in NC who live in rural areas. We will be interviewing 30 rural cancer patients to learn about their cancer experience and we will be reviewing previously completed surveys about their distress and coping behaviors.

Our study will survey 7,500 adults ages 18-59 who identify as alcohol drinkers. We aim to assess participant sources of alcohol, their drinking behavior, and associated harms before, during, and late in the COVID-19 pandemic. We will be recruiting participants from five different states so we can look at differences across a variety of state alcohol policy environments.

To increase access to Pre-Exposure Prophylaxis (PrEP) across North Carolina. HIV Pre-Exposure Prophylaxis (PrEP) medication has been proven to be effective at preventing HIV infection when taken as prescribed. Even though PrEP has been shown to be effective, not all health care settings currently offer PrEP to their patients. Part of the reason for this is that there are not enough health care providers who prescribe PrEP, and, some people have difficulty getting the cost of PrEP and PrEP care covered. The purpose of this study is to test new ways to increase access to PrEP for people in North Carolina. The intervention will test whether providing access to resources related to PrEP care at health department sexually transmitted infection (STI) clinics will increase the number of people who start using PrEP.

To establish the recommended Phase II dose of a flavored preparation of orally administered irinotecan (VAL-413) when given in combination with temozolomide for 5 consecutive days.

To evaluate the effectiveness of a brief alcohol intervention (BAI) vs. standard of care (SOC) to improve pre-exposure prophylaxis (PrEP) use among men who have sex with men (MSM) with unhealthy alcohol use initiating or re-initiating PrEP in Vietnam.

Our researchers are interviewing Mental Health First Aid training participants (MHFAiders) at UNC-CH to understand their experiences and thoughts related to the program, in order to better evaluate and cater to the needs of our university and community.

1. To create a prospective cohort of pediatric IBD patients with active disease initiating or changing medical, dietary, or surgical therapy. 2. Identify unique subgroups of pediatric patients with high likelihood of response/non-response to specific therapies through integrated analysis of demographic, clinical, and multi-omic molecular data. 3. Define surgical, clinical, and endoscopic outcomes of ileal surgery for pediatric Crohn's disease and clinical and molecular predictors of post-operative endoscopic disease recurrence.

The purpose of this research study is to learn more about what marijuana users' think of the of current marijuana warnings on the packages and to get their feedback on newly developed marijuana warnings. Participants will be recruited to participate in a one-time online focus group discussion. The total study duration will be 60-90 minutes. During the focus group participates will be asked about their understanding of the risks of using marijuana products and provide their reaction to current and improved marijuana warnings.